Pharmacology, Toxicology and Pharmaceutical Science
Cannabis
100%
Tetrahydrocannabinol
62%
Cannabidiol
56%
Blindness
45%
Psychosis
44%
Normal Human
27%
Cannabinoid
27%
Placebo
26%
Dronabinol
24%
Randomized Clinical Trial
21%
Resin
21%
Adverse Event
21%
Depression
21%
Inflammation
21%
Tetrahydrocannabivarin
21%
Anandamide
16%
Nabiximols
9%
Endocannabinoid System
9%
Symptom
8%
Inhalation
8%
Clinical Trial
8%
Benign Childhood Epilepsy
8%
Enalapril Maleate
8%
Cannabinoid Receptor
7%
Diarrhea
5%
Pneumonia
5%
2-Arachidonoylglycerol
5%
Schizophrenia
5%
Dopamine
5%
Lipid
5%
Somnolence
5%
Medicine and Dentistry
Cannabis
44%
Cannabinoid
42%
Psychosis
42%
Cannabidiol
30%
Therapeutic Procedure
23%
Tetrahydrocannabinol
23%
Cannabinoid Receptor Agonist
21%
Human Study
21%
Stress
21%
Alcohol Consumption
21%
Death
21%
Serositis
21%
Persecutory Delusion
21%
Anxiety
21%
Resin
21%
Analysis
21%
Nabiximols
7%
Cannabis Use
5%
Nursing and Health Professions
Cannabis
76%
Cannabidiol
50%
Volunteer
26%
Tetrahydrocannabinol
25%
Sample
24%
Cannabinoid Receptor Agonist
21%
Death
21%
Medical Cannabis
21%
Analysis
21%
Consensus
21%
Standard
21%
Dronabinol
21%
Measurement
21%
Resin
21%
Time
13%
Culture
10%
Concentration Ratio
7%
Nabiximols
7%